{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:23:38Z","timestamp":1771003418377,"version":"3.50.1"},"reference-count":23,"publisher":"FapUNIFESP (SciELO)","issue":"2a","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2006,6]]},"abstract":"<jats:p>OBJECTIVE: To identify clinical and immunological markers associated with HTLV-I associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). METHOD: 237 HTLV-I infected individuals were clinically assessed. They were classified according to the Expanded Disability Status Scale (EDSS) and Osame\u2019s Motor Disability Score (OMDS). Cytokine levels were determined in HTLV-I seropositive individuals. RESULTS: 37 patients had HAM\/TSP. There was a correlation between the degrees of disability assessed by both scales. There was also a correlation between the duration of HAM\/TSP and the severity of disability assessed by either EDSS or OMDS. Higher levels of IFN-gamma were detected in unstimulated peripheral blood mononuclear cells (PBMC) from HAM\/TSP patients as compared with HTLV-I carriers. CONCLUSION: This study shows the validity of the neurological scales to classify the degree of neurological disability in HTLV-I carriers and suggests a progressive behavior of HAM\/TSP. This study also shows that IFN-gamma in PBMC supernatants are markers of HAM\/TSP.<\/jats:p>","DOI":"10.1590\/s0004-282x2006000200009","type":"journal-article","created":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T17:56:37Z","timestamp":1154541397000},"page":"217-221","source":"Crossref","is-referenced-by-count":15,"title":["Association of cytokines, neurological disability, and disease duration in HAM\/TSP patients"],"prefix":"10.1590","volume":"64","author":[{"given":"Andr\u00e9 Luiz","family":"Muniz","sequence":"first","affiliation":[{"name":"Universidade Federal da Bahia, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldyr","family":"Rodrigues Jr.","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvane B.","family":"Santos","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e9lia R. de","family":"Jesus","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lia F.","family":"Porto","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e9viton","family":"Castro","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamary","family":"Oliveira-Filho","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana Passos","family":"Almeida","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ot\u00e1vio","family":"Moreno-Carvalho","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Liquorologia SIMPEL, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar M.","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1097\/00042560-199600001-00017","article-title":"Cellular immune responses to HTLV-I: immunopathogenic role in HTLV-I-associated neurologic disease","volume":"13","author":"Jacobson S","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol","ISSN":"https:\/\/id.crossref.org\/issn\/1077-9450","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00019052-200106000-00019","article-title":"Immunopathogenesis of human T cell lymphotropic virus type I-associated myelopathy","volume":"14","author":"Nagai M","year":"2001","journal-title":"Curr Opin Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/1350-7540","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0140-6736(87)90870-1","article-title":"Tropical spastic paraparesis","volume":"2","author":"Zaninovic V","year":"1987","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1182\/blood-2003-04-1043","article-title":"Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines","volume":"102","author":"Chung HK","year":"2003","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1537-2995.1997.37297203532.x","article-title":"Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study","volume":"37","author":"Galv\u00e3o-Castro B","year":"1997","journal-title":"Transfusion","ISSN":"https:\/\/id.crossref.org\/issn\/0041-1132","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00126334-200105010-00001","article-title":"Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors","volume":"27","author":"Carvalho EM","year":"2001","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1212\/WNL.41.4.594","article-title":"Interleukin-6 in cerebrospinal fluid of HTLV-I-associated myelopathy","volume":"41","author":"Ohbo K","year":"1991","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0022-510X(96)00025-1","article-title":"Immunological features of HTLV-I myelopathy in Rio de Janeiro, Brazil, and in vitro effects of cyclosporin","volume":"139","author":"Andrada-Serpa MJ","year":"1996","journal-title":"J Neurol Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0022-510X","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0022-510X(90)90217-B","article-title":"Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy\/tropical spastic paraparesis","volume":"97","author":"Nishimoto N","year":"1990","journal-title":"J Neurol Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0022-510X","issn-type":"print"},{"key":"ref10","series-title":"Human retrovirology: HTLV","first-page":"191","volume-title":"Review of WHO Kagoshima meeting and diagnostic guidelines for HAM\/TSP","author":"Osame M","year":"1990"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/WNL.46.4.1016","article-title":"Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial","volume":"46","author":"Izumo S","year":"1996","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke JF","year":"1983","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-510X(94)00266-Q","article-title":"Progression of neurological disability in HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"129","author":"Araujo AQ","year":"1995","journal-title":"J Neurol Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0022-510X","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood.V98.3.721","article-title":"High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells","volume":"98","author":"Hanon E","year":"2001","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2334-4-7","article-title":"Exacerbated inflammatory cellular immune response characteristics of HAM\/TSP is observed in a large proportion of HTLV-I asymptomatic carriers","volume":"4","author":"Santos SB","year":"2004","journal-title":"BMC Infect Dis"},{"key":"ref16","first-page":"641","article-title":"Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis","volume":"35","author":"Porto MA","year":"2002","journal-title":"Rev Soc Bras Med Trop","ISSN":"https:\/\/id.crossref.org\/issn\/0037-8682","issn-type":"print"},{"key":"ref17","first-page":"427","article-title":"Interleukin-10 in the brain","volume":"21","author":"Strle K","year":"2001","journal-title":"Crit Rev Immunol","ISSN":"https:\/\/id.crossref.org\/issn\/1040-8401","issn-type":"print"},{"key":"ref18","series-title":"Interleukin-10","first-page":"91","volume-title":"IL-10 in human Leishmaniasis","author":"Carvalho EM","year":"1995"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","article-title":"IL-10 inhibits cytokine production by activated macrophages","volume":"147","author":"Fiorentino DF","year":"1991","journal-title":"J Immunol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1767","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-3024.2001.00407.x","article-title":"HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis","volume":"23","author":"Porto AF","year":"2001","journal-title":"Parasite Immunol","ISSN":"https:\/\/id.crossref.org\/issn\/0141-9838","issn-type":"print"},{"key":"ref21","first-page":"144","article-title":"Cerebrospinal fluid analysis and the pathogenesis of central nervous system infection by HTLV-I","volume":"55","author":"Puccioni-Sohler M","year":"1997","journal-title":"Arq Neuropsiquiatr","ISSN":"https:\/\/id.crossref.org\/issn\/0004-282X","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1086\/427560","article-title":"Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"191","author":"Porto AF","year":"2005","journal-title":"J Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1590\/S0074-02762004000900022","article-title":"Clinical and immunological consequences of human T cell leukemia virus type-I and Schistosoma mansoni co-infection","volume":"99","author":"Santos SB","year":"2004","journal-title":"Mem Inst Oswaldo Cruz","ISSN":"https:\/\/id.crossref.org\/issn\/0074-0276","issn-type":"print"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v64n2a\/a09v642a.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T11:21:51Z","timestamp":1683544911000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2006000200009&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":23,"journal-issue":{"issue":"2a","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0004-282X2006000200009"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x2006000200009","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}